NL-OMON40322
Not yet recruiting
Not Applicable
Validation of multiparametric MRI with histopathology for prostate cancer - Validation of multiparametric MRI of prostate cancer
ederlands Kanker Instituut0 sites15 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- histopathology
- Sponsor
- ederlands Kanker Instituut
- Enrollment
- 15
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with biopsy\-proven prostate cancer who are scheduled for a prostatectomy
Exclusion Criteria
- •Contra\-indications for a MRI exam according to the standard protocol for the screening of patients with prostate cancer
- •Treatment of prostate cancer prior to the MRI exams
- •Prior hormonal therapy
- •Prior trans\-urethral resection (TURP)
- •GFR \< 30 ml/min/1,73 m²
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Test-retest validation of quantitative MRI in healthy volunteersNL-OMON49913Antoni van Leeuwenhoek Ziekenhuis200
Not yet recruiting
Not Applicable
Development of a multiparametric MRI protocol for Evaluation of morphology, ventilation and perfusion of the lung without contrast media.lung diseasecystic fibrosisJ00-J99Diseases of the respiratory systemDRKS00020802niversitätsklinikum Ulm350
Completed
Not Applicable
MR in ovarian cancerISRCTN51246892Imperial College London (UK)648
Completed
Not Applicable
Validation of non-radiative MRI-based multi-atlas attenuation correction for single-photon emission computed tomographyG20.0DRKS00032584niklinik Köln, Klinik für Nuklearmedizin12
Recruiting
Not Applicable
sefulness of quantitative MRI in the evaluation of pancreatic fibrosis and evaluation of residual pancreatic exocrine functiopancreatic tumorJPRN-UMIN000050347Kawasaki Medical School40